Top-News

Lunai Bioworks Aktie News

Aktie
WKN:  A41K8P ISIN:  US29350E2037 US-Symbol:  LNAI Branche:  Biotechnologie Land:  USA
1,25 $
-0,05 $
-3,85%
1,0735 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
210,63 Mio. €
Streubesitz
51,12%
KGV
-
Index-Zuordnung
-

Lunai Bioworks News

25.11.25 - PR Newswire
Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models
Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models PR Newswire
07.11.25 - PR Newswire
Lunai Bioworks schafft es, sowohl primäre als auch metastasierte Bauchspeicheldrüsentumoren in präklinischen humanisierten Modellen komplett zurückzubilden, was einen Durchbruch in der allogenen Krebsimmuntherapie bedeutet
Lunai Bioworks schafft es, sowohl primäre als auch metastasierte Bauchspeicheldrüsentumoren in präklinischen humanisierten Modellen komplett zurückzubilden, was einen ...
06.11.25 - PR Newswire
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer ...
05.11.25 - PR Newswire
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer ...
29.07.25 - PR Newswire
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks PR Newswire
29.07.25 - PR Newswire
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks PR Newswire
10.06.25 - PR Newswire
Smart Healthcare Is Taking Over. Here's Where the Money's Headed
Smart Healthcare Is Taking Over. Here's Where the Money's Headed PR Newswire
10.06.25 - PR Newswire
Smart Healthcare Is Taking Over. Here's Where the Money's Headed
Smart Healthcare Is Taking Over. Here's Where the Money's Headed PR Newswire
23.05.25 - PR Newswire
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge PR Newswire
23.05.25 - PR Newswire
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge PR Newswire
04.04.25 - GlobeNewswire
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-​generation diagnostics, drug discovery, and ...
03.03.25 - GlobeNewswire
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
Company Commits the First Tranche of Financing to Initiate the Integration of AI/ML Platform Technologies, Core Laboratory Capabilities and Business Development Efforts in ...
26.02.25 - GlobeNewswire
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond
26.02.25 - GlobeNewswire
Renovaro Announces $15 million in Equity Committed
LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today ...
19.02.25 - PR Newswire
Investors Eye Biotech Sector as Cancer Therapy Market Surges
Investors Eye Biotech Sector as Cancer Therapy Market Surges PR Newswire
07.01.25 - GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
Company to Host International Roadshow the Week of January 13, 2025
07.01.25 - GlobeNewswire
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. 07, 2025 ...
06.01.25 - GlobeNewswire
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades of longitudinal drug ...
30.12.24 - GlobeNewswire
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization
23.12.24 - GlobeNewswire
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-​omics Biomarkers and AI

Newssuche

Videos

newspaper
18:20 Uhr
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »